Acute parvovirus B19 infection: Analysis of 46 patients
Autor: | Agustín España, Alejandra Tomás-Velázquez, Gabriel Reina, Ángela Estenaga Pérez de Álbeniz, Ángela Escribano, Nuria Rodríguez-Garijo |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
biology Parvovirus Anemia business.industry Incidence (epidemiology) Retrospective cohort study biology.organism_classification medicine.disease Dermatology Rash Serology 03 medical and health sciences 0302 clinical medicine Epidemiology Maculopapular rash medicine 030212 general & internal medicine medicine.symptom business |
Zdroj: | Medicina Clínica (English Edition). 155:26-29 |
ISSN: | 2387-0206 |
DOI: | 10.1016/j.medcle.2019.12.005 |
Popis: | Introduction Parvovirus B19 (PVB19) infection has a high incidence and worldwide distribution. It has a broad clinical spectrum, with skin, joint and haematological manifestations being the most common. The objective of this study was to determine the epidemiology and clinical–analytical manifestations of acute PVB19 infection. Patients and methods A retrospective study of patients with a positive IgM serology for PVB19 (10 years). Forty-six patients were included and their demographic, clinical and analytical characteristics were analyzed. Results Primary infection was most prevalent in women (ratio 2.2:1) aged 41 (mean age). Joint involvement was the most common manifestation (65%). Skin abnormalities were observed in more than half of patients (24 cases): rash (28%), megalerythema (9%), “gloves and socks” involvement (6.5%), periflexural rash (4%) and oedema (4%). Anaemia was the main haematological alteration (35%). The symptoms were self-limiting and resolved in 1–2 weeks in most patients. Conclusions Although there is a variable clinical spectrum, polyarthralgias and generalized maculopapular rash with fever and anaemia are the typical and most frequent manifestations of primary infection by PVB19 and are usually self-limiting. |
Databáze: | OpenAIRE |
Externí odkaz: |